CD8A and neoplasm: Indeed, using a syngeneic mouse bladder tumor model, we showed that RXRαS427F reduced tumor infiltration of CD8+ T cells, and conferred partial resistance to checkpoint blockade treatment (Fig. 5 c,d, Supplementary Fig. 26).